Gilead is one of our favorite biopharmaceutical companies. Over the years, they have done a terrific job of developing and commercializing innovative medicines designed to treat or cure diseases that currently…
We spend most of our time here at the OptionsEdge.Com discussing individual companies as we seek low(er) risk trading ideas/suggestions. As we do so, we often have a vision of…
The COVID-19 outbreak has led to the savage disruption of retail the world over. Almost overnight, foot traffic in physical stores disappeared, and supply chains were left scrambled. Now at a…
Anyone who as followed the markets for a long time (like longer than 20 years) should recognize that we are in a dystopic environment. Our fellow brothers and sisters are…
Given the Fed's massive adventures into Quantitative Easing 4, one might think the price of Gold and Silver would be breaking out to all-time highs. This article is for paid…
Micron Technologies (MU) is a company that does not have the sex appeal of NVIDIA or Intel. Nor does it have the momentum of Advanced Micro Devises, but it is…
We have a big economic calendar this week with employment reports at the end of the week. The Covid-19 pandemic is still present and affecting countries across the globe. Protestors…
On Friday's airing of Options Action, the Chart Master Carter Braxton Worth took a sharper eye to small-cap stocks. The Russell 2000 is the benchmark index that both professional and…
Anyone who owned Wendys going into the COVID strike had a heart attack as the stock plummeted. Sellers were fearful that the lockdown would send sales to zero or nearly…
In 2019, nearly 70% of U.S. GDP was driven by personal consumption. However, in the first quarter of 2020, the COVID-19 pandemic has initiated a transformation of consumer spending trends as…